Health
Merck ends COVID vaccine program, cites inferior immune responses – Reuters
Drugmaker Merck & Co said on Monday it would stop development of its two COVID-19 vaccines and focus pandemic research on treatments, with initial data on an experimental…
(Reuters) – Drugmaker Merck & Co said on Monday it would stop development of its two COVID-19 vaccines and focus pandemic research on treatments, with initial data on an experimental oral antiviral expected by the end of March.
FILE PHOTO: A scientist is seen in the Themis Bioscience laboratory in Vienna, Austria, in this undated handout photo. Themis Bioscience/Martin Wacht/Handout via REUTERS /File Photo
Merck was late to join the race to develop a vaccine to protect against the coronavirus, which…
-
General19 hours agoRestaurants on the brink as business failures plateau
-
General22 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank
-
General19 hours agoRegional house price growth outstrips capital cities
-
General16 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore